Home » Topics » Regulatory » Patents

Patents
RSS

Aventis imparts new tubulin polymerization inhibitors for cancer therapy

Feb. 14, 2005

New anticoagulant agents reported by Bristol-Myers Squibb

Feb. 14, 2005

Three series of chemokine CCR4 receptor modulators claimed by AstraZeneca

Feb. 14, 2005

Novel PARP-1 inhibitors described by Altana Pharma in recent patent

Feb. 11, 2005

Novel protein tyrosine kinase inhibitors and their use as anticancer agents

Feb. 11, 2005

Anti-CD3 monoclonal antibodies with reduced immunogenicity claimed by Alexion

Feb. 11, 2005

Abbott presents new dopamine D3 modulators for schizophrenia

Feb. 11, 2005

Novel anticoagulant agents discovered at Lilly

Feb. 11, 2005

New tyrosine kinase inhibitors identified at Boehringer Ingelheim

Feb. 11, 2005

Beth Israel claims imatinib mesylate/rapamycin combination for vascular stenosis and restenosis

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...